Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 40

1.

The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cells.

Broecker-Preuss M, Becher-Boveleth N, Müller S, Mann K.

Cancer Cell Int. 2016 Apr 2;16:27. doi: 10.1186/s12935-016-0303-8. eCollection 2016.

2.

Cell Death Induction by the Indirubin Derivative 7BIO and the BH3 Mimetic Drugs ABT-737 and GX15-070 in Medullary Thyroid Carcinoma Cells.

Broecker-Preuss M, Becher-Boveleth N, Mann K.

Exp Clin Endocrinol Diabetes. 2016 Feb 5. [Epub ahead of print]

PMID:
26849668
3.

Anemia and Mild Cognitive Impairment in the German General Population.

Dlugaj M, Winkler A, Weimar C, Dürig J, Broecker-Preuss M, Dragano N, Moebus S, Jöckel KH, Erbel R, Eisele L; Heinz Nixdorf Recall Study Investigative Group.

J Alzheimers Dis. 2015;49(4):1031-42. doi: 10.3233/JAD-150434.

PMID:
26599053
4.

Thyroid-Stimulating Hormone and Mild Cognitive Impairment: Results of the Heinz Nixdorf Recall Study.

Winkler A, Weimar C, Jöckel KH, Erbel R, Dragano N, Broecker-Preuss M, Moebus S, Führer-Sakel D, Dlugaj M.

J Alzheimers Dis. 2015;49(3):797-807. doi: 10.3233/JAD-150561.

PMID:
26519440
5.

Induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3'-oxime (7BIO).

Broecker-Preuss M, Becher-Boveleth N, Gall S, Rehmann K, Schenke S, Mann K.

Cancer Cell Int. 2015 Oct 12;15:97. doi: 10.1186/s12935-015-0251-8. eCollection 2015.

6.

Chronic Kidney Disease Distinctly Affects Relationship Between Selenoprotein P Status and Serum Thyroid Hormone Parameters.

Reinhardt W, Dolff S, Benson S, Broecker-Preuß M, Behrendt S, Hög A, Führer D, Schomburg L, Köhrle J.

Thyroid. 2015 Oct;25(10):1091-6. doi: 10.1089/thy.2015.0097. Epub 2015 Sep 8.

PMID:
26348725
7.

Cell death induction by the BH3 mimetic GX15-070 in thyroid carcinoma cells.

Broecker-Preuss M, Viehof J, Jastrow H, Becher-Boveleth N, Fuhrer D, Mann K.

J Exp Clin Cancer Res. 2015 Jul 22;34:69. doi: 10.1186/s13046-015-0186-x.

8.

Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.

Broecker-Preuss M, Müller S, Britten M, Worm K, Schmid KW, Mann K, Fuhrer D.

BMC Cancer. 2015 Mar 26;15:184. doi: 10.1186/s12885-015-1186-0.

9.

NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: the Heinz Nixdorf Recall Study.

Kara K, Lehmann N, Neumann T, Kälsch H, Möhlenkamp S, Dykun I, Broecker-Preuss M, Pundt N, Moebus S, Jöckel KH, Erbel R, Mahabadi AA.

Int J Cardiol. 2015 Mar 15;183:155-61. doi: 10.1016/j.ijcard.2015.01.082. Epub 2015 Jan 29.

PMID:
25666125
10.

Unusual ratio between free thyroxine and free triiodothyronine in a long-lived mole-rat species with bimodal ageing.

Henning Y, Vole C, Begall S, Bens M, Broecker-Preuss M, Sahm A, Szafranski K, Burda H, Dammann P.

PLoS One. 2014 Nov 19;9(11):e113698. doi: 10.1371/journal.pone.0113698. eCollection 2014.

11.

Expression of the cAMP binding protein EPAC1 in thyroid tumors and growth regulation of thyroid cells and thyroid carcinoma cells by EPAC proteins.

Broecker-Preuss M, Baten J, Sheu-Grabellus SY, Görges R, Bockisch A, Schmid KW, Führer D, Mann K.

Horm Metab Res. 2015 Mar;47(3):200-8. doi: 10.1055/s-0034-1390484. Epub 2014 Nov 5.

PMID:
25372777
12.

B-type natriuretic peptide predicts stroke of presumable cardioembolic origin in addition to coronary artery calcification.

Kara K, Gronewold J, Neumann T, Mahabadi AA, Weimar C, Lehmann N, Berger K, Kälsch HI, Bauer M, Broecker-Preuss M, Möhlenkamp S, Moebus S, Jöckel KH, Erbel R, Hermann DM.

Eur J Neurol. 2014 Jun;21(6):914-21. doi: 10.1111/ene.12411. Epub 2014 Mar 24.

PMID:
24661834
13.

Metabolic and psychological response to 7-day fasting in obese patients with and without metabolic syndrome.

Li C, Ostermann T, Hardt M, Lüdtke R, Broecker-Preuss M, Dobos G, Michalsen A.

Forsch Komplementmed. 2013;20(6):413-20. doi: 10.1159/000353672. Epub 2013 Jun 28.

14.

Immune stimulation by exogenous melatonin during experimental endotoxemia.

Effenberger-Neidnicht K, Brencher L, Broecker-Preuss M, Hamburger T, Petrat F, de Groot H.

Inflammation. 2014 Jun;37(3):738-44. doi: 10.1007/s10753-013-9792-y.

PMID:
24385237
15.

Safety of poly (ethylene glycol)-coated perfluorodecalin-filled poly (lactide-co-glycolide) microcapsules following intravenous administration of high amounts in rats.

Ferenz KB, Waack IN, Laudien J, Mayer C, Broecker-Preuss M, Groot Hd, Kirsch M.

Results Pharma Sci. 2014 Apr 30;4:8-18. doi: 10.1016/j.rinphs.2014.04.001. eCollection 2014.

16.

Coronary atherosclerosis burden, but not transient troponin elevation, predicts long-term outcome in recreational marathon runners.

Möhlenkamp S, Leineweber K, Lehmann N, Braun S, Roggenbuck U, Perrey M, Broecker-Preuss M, Budde T, Halle M, Mann K, Jöckel KH, Erbel R, Heusch G.

Basic Res Cardiol. 2014 Jan;109(1):391. doi: 10.1007/s00395-013-0391-8. Epub 2013 Nov 19.

PMID:
24253174
17.

Effects of glycine, pyruvate, resveratrol, and nitrite on tissue injury and cytokine response in endotoxemic rats.

Hamburger T, Broecker-Preuss M, Hartmann M, Schade FU, de Groot H, Petrat F.

J Surg Res. 2013 Jul;183(1):e7-e21. doi: 10.1016/j.jss.2013.01.024. Epub 2013 Feb 8.

PMID:
23434211
18.

Prevalence and incidence of anemia in the German Heinz Nixdorf Recall Study.

Eisele L, Dürig J, Broecker-Preuss M, Dührsen U, Bokhof B, Erbel R, Moebus S, Jöckel KH; Heinz Nixdorf Recall Study Investigative Group.

Ann Hematol. 2013 Jun;92(6):731-7. doi: 10.1007/s00277-013-1697-1. Epub 2013 Feb 21.

PMID:
23430088
19.

RANKL-associated suppression of particle-induced osteolysis in an aged model of Calcitonin and α-CGRP deficiency.

Kauther MD, Neuerburg C, Wefelnberg F, Bachmann HS, Schlepper R, Hilken G, Broecker-Preuss M, Grabellus F, Schilling AF, Jäger M, Wedemeyer C.

Biomaterials. 2013 Apr;34(12):2911-9. doi: 10.1016/j.biomaterials.2013.01.034. Epub 2013 Jan 26.

PMID:
23357366
20.

Cardiac risk in patients with treatment naïve, first-line medically controlled and first-line surgically cured acromegaly in comparison to matched data from the general population.

Berg C, Petersenn S, Walensi M, Möhlenkamp S, Bauer M, Lehmann N, Roggenbuck U, Moebus S, Broecker-Preuss M, Sandalcioglu IE, Stolke D, Sure U, Joeckel KH, Erbel R, Führer D, Mann K; Investigative Group of the Heinz Nixdorf Recall Study.

Exp Clin Endocrinol Diabetes. 2013 Feb;121(2):125-32. doi: 10.1055/s-0032-1314811. Epub 2013 Jan 21.

PMID:
23338744
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk